Affiliation:
1. Department of Pharmaceutics and Social Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa P.O. Box 9086, Ethiopia
2. Edinburgh Business School, Heriot Watt University, Edinburgh EH14 4AS, UK
Abstract
Background: Ensuring the consistent availability of essential medicines is crucial for effective healthcare systems. However, Ethiopian public health facilities have faced frequent stockouts of crucial medications, highlighting systemic challenges such as inadequate forecasting, prolonged procurement processes, a disjointed distribution system, suboptimal data quality, and a shortage of trained professionals. This study focuses on the Ethiopian Pharmaceutical Supply Services (EPSS), known for its highly unstable and volatile supply chain, aiming to identify risks and mitigation strategies. Methods: Using a mixed-method approach involving surveys and interviews, the research investigates successful and less successful strategies, key success factors, and barriers related to pharmaceutical shortages. Results: Proactive measures such as communication, stock assessment, supervision, and streamlined procurement are emphasized as vital in mitigating disruptions, while reactive strategies like safety stock may lack long-term efficacy. The study highlights the importance of aligning supply chain strategies with product uncertainties, fostering collaboration, and employing flexible designs for resilience. Managerial implications stress the need for responsive structures that integrate data quality, technology, and visibility. Conclusions: This study contributes by exploring proactive and reactive strategies, elucidating key success factors for overcoming shortages in countries with unstable supply chains, and offering actionable steps for enhancing supply chain resilience. Embracing uncertainty and implementing proactive measures can help navigate volatile environments, thereby enhancing competitiveness and sustainability.
Reference98 articles.
1. Essential medicines twenty-five years on: Closing the access gap;Quick;Health Policy Plan.,2003
2. World Health Organization (2004). Annual Report 2003: Essential Drugs and Medicines Policy, World Health Organization. (No. WHO/EDM/2004.1).
3. World Health Organization (2004). WHO Medicines Strategy 2004–2007: Countries at the Core, World Health Organization. (No. WHO/EDM/2004.5).
4. Poor availability of essential medicines for women and children threatens progress towards Sustainable Development Goal 3 in Africa;Droti;BMJ Glob. Health,2019
5. Impact of drug shortages on US health systems;Kaakeh;Am. J. Health-Syst. Pharm.,2011